Aptevo Therapeutics (APVO) Earnings Date, Estimates & Call Transcripts → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free APVO Stock Alerts $0.72 -0.01 (-1.78%) (As of 02:11 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 8) -$9.95 Beat By $4.15 Consensus EPS (May. 8) -$14.10 Get Aptevo Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for APVO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAPVO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.APVO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressThe Tesla Indicator Is BullishIf you ever thought you’re too late to see significant returns from Tesla stock… Please read this short email. Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla. It’s all thanks to one unique trade setup that’s specific to this legendary stock. It’s called the Perfect Tesla Trade. And it couldn’t be more straightforward…>> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo Aptevo Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241($1.93)($1.93)($1.93)Q3 20241($1.71)($1.71)($1.71)Q4 20241($1.70)($1.70)($1.70)APVO Earnings Date and InformationAptevo Therapeutics last announced its earnings data on May 8th, 2024. The biotechnology company reported ($9.95) earnings per share for the quarter, beating analysts' consensus estimates of ($14.10) by $4.15. Aptevo Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Aptevo Therapeutics are expected to grow in the coming year, from ($8.86) to ($5.77) per share. Aptevo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Aptevo Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024(Estimated)------- 5/8/2024Q1 2024($14.10)($9.95)+$4.15($9.95)--11/14/2023Q3 2023($28.16)($22.00)+$6.16($0.50)--8/10/2023Q2 2023($49.28)($54.12)($4.84)($1.23)--5/11/2023Q1 2023($52.36)$11.44+$63.80$0.13--11/10/2022Q3 2022($72.16)($67.32)+$4.84($1.56)--8/11/2022Q2 2022($58.52)($81.84)($23.32)($9.30)-- Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2022Q1 2022($50.60)($69.96)($19.36)($1.63)$3.75 million$3.11 million 3/24/2022Q4($56.98)($55.88)+$1.10---11/12/2021Q3 2021($65.12)($63.80)+$1.32($1.47)$3.65 million$3.10 million8/11/2021Q2($80.96)($78.32)+$2.64($1.81)$2.70 million$3.11 million 5/11/2021Q1 2021($71.28)($76.56)($5.28)($1.84)$2.10 million$2.42 million3/30/2021Q4($53.46)($84.48)($31.02)---11/15/2020Q3($90.20)($94.60)($4.40)($2.20)$0.49 million$1.46 million 8/14/2020Q2 2020($99.88)($92.40)+$7.48($2.10)$0.29 million$0.47 million5/13/2020Q1 2020($103.40)($124.96)($21.56)($5.73)$4.50 million-11/7/2019Q3($10.56)($10.12)+$0.44($0.30)$8.05 million$9.01 million8/9/2019Q2 2019($14.52)($13.20)+$1.32($0.30)$6.95 million$7.36 million Aptevo Therapeutics Earnings - Frequently Asked Questions When is Aptevo Therapeutics's earnings date? Aptevo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on APVO's earnings history. Did Aptevo Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aptevo Therapeutics (NASDAQ:APVO) reported ($9.95) earnings per share (EPS) to beat the analysts' consensus estimate of ($14.10) by $4.15. Learn more on analysts' earnings estimate vs. APVO's actual earnings. How much revenue does Aptevo Therapeutics generate each year? Aptevo Therapeutics (NASDAQ:APVO) has a recorded annual revenue of $3.11 million. How much profit does Aptevo Therapeutics generate each year? Aptevo Therapeutics (NASDAQ:APVO) has a recorded net income of -$17.41 million. APVO has generated $0.00 earnings per share over the last four quarters. What is Aptevo Therapeutics's EPS forecast for next year? Aptevo Therapeutics's earnings are expected to grow from ($8.86) per share to ($5.77) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MBIO Earnings ADXS Earnings SNOA Earnings CYCC Earnings ZVSA Earnings LGVN Earnings QNRX Earnings ONCO Earnings ARAV Earnings SXTP Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Abercrombie & Fitch First Quarter Earnings Surge to New HeightsTD Bank Q2 Earnings: Record Highs and Regulatory HurdlesPDD Holdings Earnings Volatility Alerts Buyers Zoom Stock’s Earnings Volatility Picked Up a Lot of BuyersBaidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the Dip This page (NASDAQ:APVO) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWho are Nvidia’s New Silent Partners?Weiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
